Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.

These results suggest that pan-Trk immunoreactivity with a nuclear and cytoplasmic staining pattern may be useful to identify ETV6-NTRK3-positive IMTs and may be helpful in selecting patients for Trk-targeted therapy.